 
        
        
         
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | PLK1 ↓ ↑ | PLK2 ↓ ↑ | PLK3 ↓ ↑ | PLK4 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HMN-214 | ✔ | 99%+ | |||||||||||||||||
| SBE13 HCl | ++++ PLK1, IC50: 200 pM | 98% | |||||||||||||||||
| Onvansertib | +++ PLK1, IC50: 2 nM | 99%+ | |||||||||||||||||
| Volasertib | ++++ PLK1, IC50: 0.87 nM | 97% | |||||||||||||||||
| GSK461364 | +++ PLK1, Ki: 2.2 nM | 99%+ | |||||||||||||||||
| MLN0905 | +++ PLK1, IC50: 2 nM | 99%+ | |||||||||||||||||
| Ro3280 | ++ PLK1, IC50: 3 nM | 99% | |||||||||||||||||
| (E/Z)-Rigosertib sodium | + PLK1, IC50: 9 nM | + PLK2, IC50: 260 nM | Bcr-Abl | 99%+ | |||||||||||||||
| BI 2536 | ++++ PLK1, IC50: 0.83 nM | ++ PLK2, IC50: 3.5 nM | + PLK3, IC50: 9.0 nM | 99%+ | |||||||||||||||
| CFI-400945 | ++ PLK4, IC50: 2.8 nM | Tie-2 | 98% | ||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | RO3280 is a potent, highly selective inhibitor of Polo-like kinase 1 (PLK1) with IC50 of 3 nM. | 
| Concentration | Treated Time | Description | References | |
| NB4 | 74 nM | 24 hours | RO3280 inhibits leukemia cell proliferation with IC50 of 74 nM | Int J Mol Sci. 2015 Jan 7;16(1):1266-92. | 
| HL60 | 175 nM | 24 hours | RO3280 inhibits leukemia cell proliferation with IC50 of 175 nM | Int J Mol Sci. 2015 Jan 7;16(1):1266-92. | 
| U937 | 186 nM | 24 hours | RO3280 inhibits leukemia cell proliferation with IC50 of 186 nM | Int J Mol Sci. 2015 Jan 7;16(1):1266-92. | 
| CCRF | 162 nM | 24 hours | RO3280 inhibits leukemia cell proliferation with IC50 of 162 nM | Int J Mol Sci. 2015 Jan 7;16(1):1266-92. | 
| K562 | 797 nM | 24 hours | RO3280 inhibits leukemia cell proliferation with IC50 of 797 nM | Int J Mol Sci. 2015 Jan 7;16(1):1266-92. | 
| MV4-11 | 120 nM | 24 hours | RO3280 inhibits leukemia cell proliferation with IC50 of 120 nM | Int J Mol Sci. 2015 Jan 7;16(1):1266-92. | 
| SV-HUC-1 cells | 50, 100 and 200 nM | 24 and 48 hrs | RO3280 had a weaker inhibitory effect on SV-HUC-1 cells, with a maximal inhibitory effect of only 37% | J Cell Mol Med. 2017 Apr;21(4):758-767. | 
| T24 cells | 50, 100 and 200 nM | 24 and 48 hrs | RO3280 inhibited cell growth and cell cycle progression, increased Wee1 expression and CDC2 phosphorylation, induced mitotic catastrophe and apoptosis | J Cell Mol Med. 2017 Apr;21(4):758-767. | 
| 5637 cells | 50, 100 and 200 nM | 24 and 48 hrs | RO3280 inhibited cell growth and cell cycle progression, increased Wee1 expression and CDC2 phosphorylation, induced mitotic catastrophe and apoptosis | J Cell Mol Med. 2017 Apr;21(4):758-767. | 
| NIH/3T3 cells | 2 μM | To evaluate the regulatory effect of Ro3280 on CAFs phenotype, results showed that Ro3280 reversed the activation state of CAFs. | Theranostics. 2022 May 9;12(8):3911-3927. | |
| RBE cells | 15 μM | 48 hours | To evaluate the antitumor effect of Ro3280 on cholangiocarcinoma cells, results showed that Ro3280 significantly inhibited cell proliferation and induced apoptosis. | Theranostics. 2022 May 9;12(8):3911-3927. | 
| HuCCT1 cells | 15 μM | 48 hours | To evaluate the antitumor effect of Ro3280 on cholangiocarcinoma cells, results showed that Ro3280 significantly inhibited cell proliferation and induced apoptosis. | Theranostics. 2022 May 9;12(8):3911-3927. | 
| NB4 cells | 100-500 nM | 4-12 hours | RO3280 induced autophagy in NB4 cells, increased LC3-II levels, and increased autophagosomes observed by TEM. | Oncol Rep. 2017 Mar;37(3):1419-1429. | 
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c nude mice | 5637 bladder cancer xenograft model | Intraperitoneal injection | 40 mg/kg | Once every 5 days for 40 days | RO3280 significantly inhibited the growth of 5637 xenografts, increased Wee1 expression and CDC2 phosphorylation, and decreased BubR1 expression | J Cell Mol Med. 2017 Apr;21(4):758-767. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 1.84mL 0.37mL 0.18mL | 9.20mL 1.84mL 0.92mL | 18.40mL 3.68mL 1.84mL | |
| CAS号 | 1062243-51-9 | 
| 分子式 | C27H35F2N7O3 | 
| 分子量 | 543.61 | 
| SMILES Code | O=C(NC1CCN(C)CC1)C2=CC=C(NC3=NC=C(N4C)C(N(C5CCCC5)CC(F)(F)C4=O)=N3)C(OC)=C2 | 
| MDL No. | MFCD22665717 | 
| 别名 | Ro5203280 | 
| 运输 | 蓝冰 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Keep in dark place, sealed in dry, store in freezer, under -20°C | 
| 溶解方案 | DMSO: 105 mg/mL(193.15 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 
 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1